Lu Jiang

Title: Innovator Lu Jiang: A Trailblazer in Peptide Derivatives

Introduction

Lu Jiang, an esteemed inventor based in Dallan, China, has made significant contributions to the field of pharmaceuticals. With one patent to his name, Jiang's work focuses on a peptide derivative that has promising therapeutic applications.

Latest Patents

Lu Jiang holds a patent for a "Par-2-activating peptide derivative and pharmaceutical composition using the same." This invention relates to a peptide derivative represented by the general formula (I) or a salt thereof: Z-(CH)—CO—NH-Leu-Ile-Gly-AA-AA-CO—R (I). In this formula, Z denotes an aryl or heteroaryl group, and R can be —OH or —NH. This innovative peptide derivative is recognized for its utility in treating various medical conditions, including dysfunction of masticatory, dysphagia, dry eye, and several types of ulcers.

Career Highlights

Throughout his career, Jiang has been associated with prestigious institutions, notably The University of Edinburgh and the University of Strathclyde. His dedication to research and innovation in the field of peptides has positioned him as a noteworthy contributor in the pharmaceutical industry.

Collaborations

During his time in the research field, Lu Jiang has collaborated with esteemed colleagues, including Robert Ramage and Robin Plevin. These partnerships have likely enhanced his research endeavors and fostered innovative approaches within his work.

Conclusion

Lu Jiang’s innovative contributions to peptide derivatives mark him as a key figure in the pharmaceutical realm. His invention holds promise for advancing therapeutic options for a variety of conditions, showcasing his commitment to enhancing healthcare through science and innovation.